PT-141 10 mg
- Active Substance: Bremelanotide (PT-141)
- Concentration: 10 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: PT 141
- Molecular Formula: C50H68N14O10
- Molecular Weight: 1025.18 g/mol
- Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH
- Synonyms: PT-141, Vyleesi, Bremelanotide Acetate
PT-141 10 mg – Spark of Intimate Vitality
Spark Your Sexual Health Research
Envision a lab where desire ignites, arousal intensifies, and mood elevates. PT-141 10 mg from Peptide Sciences USA makes this real. This melanocortin receptor agonist, also known as Bremelanotide, enhances libido and sexual function in men and women, offering a breakthrough for studying hypoactive sexual desire disorder (HSDD) and erectile dysfunction (ED). It's your spark for leading transformative research, crafted for trailblazing researchers like you.
The Science Behind Intimate Vitality
PT-141 (Bremelanotide, sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH) is a synthetic cyclic heptapeptide that acts as a melanocortin receptor agonist, primarily targeting MC4R and MC1R in the central nervous system. It stimulates dopamine release in the medial preoptic area, enhancing sexual arousal and desire in both sexes. In clinical trials, PT-141 (1.75 mg subcutaneous dose) improved sexual desire and reduced distress in premenopausal women with HSDD. In men, 4–6 mg doses increased erection duration by 140 minutes compared to 22 minutes for placebo, even in sildenafil non-responders.
Unlike PDE5 inhibitors (e.g., Viagra), PT-141 acts centrally, not via blood flow, making it effective for psychogenic ED and female arousal disorders. It also elevates mood and may reduce body weight in obese women. The 10 mg injectable dosage is ideal for researching sexual dysfunction, mood regulation, and potential weight loss effects, with 100% bioavailability.
Why PT-141 10 mg Fuels Your Studies
PT-141 isn't just a peptide—it's a spark that transforms sexual health research. Here's what makes it shine:
- Enhanced Libido: Boosts sexual desire in men and women via MC4R agonism.
- Erectile Dysfunction Aid: Increases erection duration (140 minutes) in sildenafil non-responders.
- Mood Elevation: Enhances dopamine signaling, improving mood and well-being.
- Non-Hormonal Action: Acts centrally without altering hormone levels.
- Top Quality: Crafted by Peptide Sciences USA with 99% purity for reliable results.
With PT-141 10 mg, you're not just studying—you're leading a breakthrough in intimate vitality and sexual health.
Product Specifications
Peptide Sciences USA's PT-141 10 mg is your key to cutting-edge sexual health studies. Here's the breakdown:
- Composition: Contains 10 mg Bremelanotide (C50H68N14O10, 1025.18 g/mol).
- Pack Size: Single vial of lyophilized powder, requiring reconstitution for subcutaneous injection.
- Manufacturing: Produced by Peptide Sciences USA with 99% purity, verified by HPLC and Mass Spectrometry.
- Usage Guidelines: Reconstitute with 1–2 mL bacteriostatic water (5–10 mg/mL). Inject 1–2 mg subcutaneously 45–60 minutes before anticipated activity, 2–3 times weekly, not exceeding 8 doses monthly. Use under professional supervision.
- Storage: Store lyophilized powder at -20°C for long-term stability or 4°C for short-term use (up to 3–4 weeks). After reconstitution, refrigerate at 2–8°C and use within 4–6 weeks.
- Safety: Common side effects include nausea (40%), flushing (20%), headache (11%), and transient blood pressure increases (6 mmHg systolic); contraindicated in uncontrolled hypertension or cardiovascular disease.
This peptide is for research purposes only, driving discoveries in sexual dysfunction and mood regulation.
Legal Disclaimer
PT-141 10 mg is supplied for research purposes only and is FDA-approved only for hypoactive sexual desire disorder (HSDD) in premenopausal women (1.75 mg subcutaneous dose, Vyleesi), per regulations as of 2025. It is not approved for men, postmenopausal women, or non-HSDD uses. It is banned by the World Anti-Doping Agency (WADA) for performance-enhancing use. It is contraindicated in uncontrolled hypertension or cardiovascular disease due to transient blood pressure spikes. Consult a licensed professional before use. Peptide Sciences USA assumes no liability for misuse. All information is educational and based on preclinical and clinical research.
Frequently Asked Questions
What does peptide PT-141 do?
PT-141 (Bremelanotide) enhances sexual desire and arousal in men and women by stimulating melanocortin receptors (MC4R) in the brain.
Is PT-141 better than Viagra?
PT-141 acts centrally to boost desire and arousal, effective for psychogenic ED, while Viagra enhances blood flow; PT-141 may work for sildenafil non-responders.
What does PT-141 feel like?
Users report heightened sexual desire, improved arousal, and enhanced mood within 30–60 minutes, often with warmth or flushing.
How long do PT-141 effects last?
Effects last 6–72 hours after subcutaneous injection, with peak arousal at 0.5–1 hour.
What is the side effect of bremelanotide?
Common side effects include nausea (40%), flushing (20%), headache (11%), and transient blood pressure spikes (6 mmHg systolic); rare hyperpigmentation.
Can you overdose on PT-141?
Overdosing (e.g., >10 mg) may increase nausea, blood pressure spikes, or prolonged erections; adhere to 1–2 mg doses, not exceeding 8 monthly.
Related Products
- Active Substance: Bremelanotide (PT-141)
- Concentration: 10 mg per vial
- Pack Size: 1 vial (lyophilized powder)
- Manufacturer: Dragon Pharma
- Brand Name: PT-141
- Molecular Formula: C50H68N14O10
- Molecular Weight: 1025.2 g/mol
- Synonyms: PT-141, Bremelanotide Acetate
- Active Substance: Epitalon
- Concentration: 50 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Epitalon
- Molecular Formula: C14H22N4O9
- Molecular Weight: 390.35 g/mol
- Sequence: Ala-Glu-Asp-Gly
- Synonyms: Epithalon, AEDG, Epithalamin analog
- Active Substance: Proxofim (FOXO4-D-Retro-Inverso)
- Concentration: 10 mg per vial
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Proxofim
- Molecular Formula: C228H388N86O64
- Molecular Weight: 5358.05 g/mol
- Sequence: H-D-Leu-D-Thr-D-Leu-D-Arg-D-Lys-D-Glu-D-Pro-D-Ala-D-Ser-D-Glu-D-Ile-D-Ala-D-Gln-D-Ser-D-Ile-D-Leu-D-Glu-D-Ala-D-Tyr-D-Ser-D-Gln-D-Asn-D-Gly-D-Trp-D-Ala-D-Asn-D-Arg-D-Arg-D-Ser-D-Gly-D-Gly-D-Lys-D-Arg-D-Pro-D-Pro-D-Pro-D-Arg-D-Arg-D-Arg-D-Gln-D-Arg-D-Arg-D-Lys-D-Lys-D-Arg-D-Gly-OH
- Synonyms: Forkhead box protein O4 D-Retro-Inverso, FOXO4a, AFX, AFX1, MLLT7
- Active Substance: HGH Fragment 176-191 (6 mg), Modified GRF (CJC-1295 No DAC, 3 mg), Ipamorelin (3 mg)
- Concentration: 12 mg per vial (6 mg HGH Fragment 176-191 + 3 mg Modified GRF + 3 mg Ipamorelin)
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Peptide Blend
- Molecular Formula (HGH Fragment 176-191): C78H125N24O24S2
- Molecular Weight (HGH Fragment 176-191): 1817.12 g/mol
- Sequence (HGH Fragment 176-191): Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
- Molecular Formula (Modified GRF): C152H252N44O42
- Molecular Weight (Modified GRF): 3367.97 g/mol
- Sequence (Modified GRF): H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
- Molecular Formula (Ipamorelin): C38H49N9O5
- Molecular Weight (Ipamorelin): 711.85 g/mol
- Sequence (Ipamorelin): Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Synonyms: HGH Fragment 176-191 (AOD9604), Modified GRF (CJC-1295 No DAC), Ipamorelin (GHRP, Ghrelin mimetic)
- Active Substance: HGH Fragment 176-191 (6 mg), CJC1295 No DAC (3 mg), Ipamorelin (3 mg)
- Concentration: 12 mg per vial (6 mg HGH Fragment 176-191 + 3 mg CJC1295 + 3 mg Ipamorelin)
- Pack Size: Single vial (lyophilized powder)
- Manufacturer: Peptide Sciences USA
- Brand Name: Peptide Blend
- Molecular Formula (HGH Fragment 176-191): C78H125N24O24S2
- Molecular Weight (HGH Fragment 176-191): 1817.12 g/mol
- Sequence (HGH Fragment 176-191): Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
- Molecular Formula (CJC1295 No DAC): C152H252N44O42
- Molecular Weight (CJC1295 No DAC): 3367.97 g/mol
- Sequence (CJC1295 No DAC): H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
- Molecular Formula (Ipamorelin): C38H49N9O5
- Molecular Weight (Ipamorelin): 711.85 g/mol
- Sequence (Ipamorelin): Aib-His-D-2-Nal-D-Phe-Lys-NH2
- Synonyms: HGH Fragment 176-191 (AOD9604), CJC1295 No DAC (Mod GRF), Ipamorelin (GHRP, Ghrelin mimetic)